Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction.

Selvaraj S, Claggett BL, Packer M, Zannad F, Anand IS, Pieske B, Zhao Z, Shi VC, Lefkowitz MP, McMurray JJV, Solomon SD

Open source

DOI
10.1161/jaha.121.022069
Published
2021 Sep 7
Container
Journal of the American Heart Association
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1161/jaha.121.022069,
  title = {Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction.},
  author = {Selvaraj S and Claggett BL and Packer M and Zannad F and Anand IS and Pieske B and Zhao Z and Shi VC and Lefkowitz MP and McMurray JJV and Solomon SD},
  year = {2021},
  journal = {Journal of the American Heart Association},
  doi = {10.1161/jaha.121.022069},
  url = {https://doi.org/10.1161/jaha.121.022069}
}

RIS

TY  - JOUR
TI  - Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction.
AU  - Selvaraj S
AU  - Claggett BL
AU  - Packer M
AU  - Zannad F
AU  - Anand IS
AU  - Pieske B
AU  - Zhao Z
AU  - Shi VC
AU  - Lefkowitz MP
AU  - McMurray JJV
AU  - Solomon SD
PY  - 2021
JO  - Journal of the American Heart Association
DO  - 10.1161/jaha.121.022069
UR  - https://doi.org/10.1161/jaha.121.022069
ER  - 

APA

S, S., BL, C., M, P., F, Z., IS, A., B, P., Z, Z., VC, S., MP, L., JJV, M., & SD, S. (2021). Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction.. Journal of the American Heart Association. https://doi.org/10.1161/jaha.121.022069

Source records